Compugen Ltd. (NASDAQ:CGEN) Q3 2024 Earnings Call Transcript
Ladies and gentlemen, thank you for joining us today. Welcome to Compugen's Third Quarter 2024 Results Conference Call. At ...
The new faces of cancer: Tragedy of young, fit women in their 20s and 30s being struck down by killer disease
Between 1990 and 2019, cases of cancer in young people across the globe have increased by 79 percent and deaths have risen 28 ...
"They Will Elect Anyone Before They Elect A Black Woman": Black Americans Are Sharing Their Brutally Honest Reactions To The 2024 Election
"Sad to say that if slavery were on the ballot today, it would overwhelmingly pass. This is how deeply Trump has stoked the ...
Pet owners report extreme alleged side effects from ‘miracle drug’ Librela for arthritic dogs
The Globe and Mail spoke with eight people whose pet’s health declined after taking Librela. Drugmaker Zoetis has responded ...
Eyenovia Provides Update on Phase 3 CHAPERONE Study
A review of study data by an independent Data Review Committee found that CHAPERONE is not meeting its primary three-year efficacy ...
Eyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Advanced Phase 3 CHAPERONE study of MicroPine as a treatment of pediatric progressive myopia with preparations for interim analysis this ...
How to Fortify Against the Trump Agenda While There’s Still Time
A violent, white supremacist regime is coming, but there is room to organize. Much can and must be done in the next few weeks ...
tbsnews2d
Wolfs: When star power makes you watch a movie
Boasting the likes of George Clooney and Brad Pitt as lead characters, ‘Wolfs’ keeps you glued to your seats more for the cast than the catchphrases ...
Yahoo1d
I Tried Everything to Treat My Hair Loss
There are also now some in-office lasers that can tackle hair loss, and some of the newer treatments don’t involve pain or ...
Yahoo News Canada2d
One Week After The Election, Black Americans Are Sharing Their Thoughts And Feelings About The Outcome, And They're Not Holding Back
"It's a hard pill to swallow, knowing that some of us got conned by Trump ... "I am a Black American woman who is also a Gen ...
Eyenovia, Inc.: Eyenovia Provides Update on Phase 3 CHAPERONE Study
A review of study data by an independent Data Review Committee found that CHAPERONE is not meeting its primary three-year efficacy endpoint Company to discontinue study, review full data set, and eval ...